Document Preview Unavailable
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breast cancer
You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library